| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2973502 | The Journal of Heart and Lung Transplantation | 2006 | 10 Pages |
Abstract
BT563/BB10 is less effective than ATG for prevention of both acute allograft rejection and allograft vasculopathy after cardiac transplantation. Clinically relevant infections or tumorgenicity were not increased with the use of ATG.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Nikolaos MD, Daniela MSc, Alfred MD, Martin MD, Michael MD, Andreas MD, Ernst MD, Günther MD,